Cited by 213Bone Metabolism and DiseasesBone health and osteoporosis researchOsteomyelitis and Bone Disorders Research

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

RANKL/OPG; Critical role in bone physiology

Martin, T. John, Sims, Natalie A.·2015·Reviews in Endocrine and Metabolic Disorders

Open this paper in CoChat — free account

Abstract

After it was proposed that the osteoblast lineage controlled the formation of osteoclasts, cell culture methods were developed that established this to be the case. Evidence was obtained that cytokines and hormones that promote osteoclast formation act first on osteoblast lineage cells to promote the production of a membrane-bound regulator of osteoclastogenesis. This proved to be receptor activator of NF-kB ligand (RANKL) a member of the tumor necrosis factor ligand family that acts upon its receptor RANK in the hematopoietic lineage, with interaction restricted by a decoy soluble receptor osteoprotegerin (OPG), also a product of the osteoblast lineage. The physiological roles of these factors were established through genetic and pharmacological studies, have led to a new physiology of bone, with complete revision of older ideas over the last 15 years, ultimately leading to the development of new pharmaceutical agents for bone disease.

Integrity signals

Registry

Crossref · 10.1007/s11154-014-9308-6

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
Self-citation
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingPreprint
Lomaga, M. A., Yeh, W., Sarosi, I., Duncan, G. S., Furlonger, C. L., Ho, A. P., Morony, S., Capparelli, C., Van, G. Y., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,265
c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling
Grigoriadis, A. E., Wang, Z., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,264
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Modulation of Osteoclast Differentiation
Suda, T., Takahashi, N., & Martin, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Self-citation
Role of osteoblasts in hormonal control of bone resorption—A hypothesis
Rodan, G. A., & Martin, T. J. (1981) · Calcified Tissue International · doi:10.1007/bf02409454 · Cited by 982
Self-citation
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 934
Self-citation
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., et al. (2004) · Nature · doi:10.1038/nature02444 · Cited by 832
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
Tsuda, E., Goto, M., Mochizuki, S.-I., Yano, K., Kobayashi, F., Morinaga, T., & Higashio, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6603 · Cited by 787
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775
Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit
Sims, N. A., & Martin, T. J. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2013.215 · Cited by 745
Self-citation
Osteoclast-Like Cell Formation and its Regulation by Osteotropic Hormones in Mouse Bone Marrow Cultures*
Takahashi, N., Yamana, H., Yoshiki, S., Roodman, G. D., Mundy, G. R., Jones, S. J., BOYDE, A., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-122-4-1373 · Cited by 731
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H. I., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 719
Osteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 661
Self-citation
Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T. S., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 626
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2653 · Cited by 542
Self-citation
Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.
Thomson, B. M., Mundy, G. R., & Chambers, T. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.775 · Cited by 540
The Bone Marrow-Derived Stromal Cell Lines MC3T3-G2/PA6 and ST2 Support Osteoclast-Like Cell Differentiation in Cocultures with Mouse Spleen Cells
Udagawa, N., Takahashi, N., Akatsu, T., Sasaki, T., Yamaguchi, A., KODAMA, H., Martin, T. J., & Suda, T. (1989) · Endocrinology · doi:10.1210/endo-125-4-1805 · Cited by 492
Self-citation
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., Macpherson, H. K., Wallace, R. G. H., Hul, W. V., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 484
Cells of bone: proliferation, differentiation, and hormonal regulation
Nijweide, P. J., Burger, E. H., & Feyen, J. H. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.855 · Cited by 474
Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
Ma, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Endocrinology · doi:10.1210/endo.142.9.8356 · Cited by 428
Self-citation
Activated T Lymphocytes Support Osteoclast Formation in Vitro
Horwood, N. J., Kartsogiannis, V., Quinn, J. M. W., Romas, E., Martin, T. J., & Gillespie, M. T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1623 · Cited by 416
Self-citation
Osteoprotegerin Produced by Osteoblasts Is an Important Regulator in Osteoclast Development and Function
Udagawa, N., Takahashi, N., Yasuda, H., Mizuno, A., Itoh, K., Ueno, Y., Shinki, T., Gillespie, M. T., Martin, T. J., Higashio, K., et al. (2000) · Endocrinology · doi:10.1210/endo.141.9.7634 · Cited by 411
Self-citation
Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing Kinase
Darnay, B. G., Ni, J., Moore, P. A., & Aggarwal, B. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7724 · Cited by 399
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
Hauge, E. M., Qvesel, D., Eriksen, E. F., Mosekilde, L., & Melsen, F. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.9.1575 · Cited by 397
Biochemical Characterization with Parathormone and Calcitonin of Isolated Bone Cells: Provisional Identification of Osteoclasts and Osteoblasts
LUBEN, R. A., Wong, G. L., & Cohn, D. V. (1976) · Endocrinology · doi:10.1210/endo-99-2-526 · Cited by 394
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.
Thomson, B. M., Saklatvala, J., & Chambers, T. J. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.1.104 · Cited by 389
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.
Lipton, A., Steger, G. G., Figueroa, J., Alvarado, C., Solal-Celigny, P., Body, J.-J., de Boer, R., Berardi, R., Gascon, P., Tonkin, K. S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8604 · Cited by 389
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Movérare‐Skrtic, S., Henning, P., Liu, X., Nagano, K., Saito, H., Börjesson, A., Sjögren, K., Windahl, S. H., Farman, H. H., Kindlund, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3654 · Cited by 369
Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D–induced inhibition of bone mineralization
Lieben, L., Masuyama, R., Torrekens, S., Looveren, R. V., Schrooten, J., Baatsen, P., Lafage‐Proust, M., Dresselaers, T., Feng, J. Q., Bonewald, L. F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45890 · Cited by 366
Bone Resorption Restored in Osteopetrotic Mice by Transplants of Normal Bone Marrow and Spleen Cells
Walker, D. G. (1975) · Science · doi:10.1126/science.1105786 · Cited by 345
The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily
Galibert, L., Tometsko, M. E., Anderson, D. M., Cosman, D. J., & Dougall, W. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34120 · Cited by 330
Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues
Kartsogiannis, V., Zhou, H., Horwood, N. J., Thomas, R. J., Hards, D. K., Quinn, J. M. W., Niforas, P., Ng, K. W., Martin, T. J., & Gillespie, M. T. (1999) · Bone · doi:10.1016/s8756-3282(99)00214-8 · Cited by 324
Self-citation
CELL PROLIFERATION AND SPECIALIZATION DURING ENDOCHONDRAL OSTEOGENESIS IN YOUNG RATS
Young, R. W. (1962) · The Journal of Cell Biology · doi:10.1083/jcb.14.3.357 · Cited by 308
Osteoblast-Like Cells in the Presence of Parathyroid Hormone Release Soluble Factor that Stimulates Osteoclastic Bone Resorption*
McSheehy, P. M. J., & Chambers, T. J. (1986) · Endocrinology · doi:10.1210/endo-119-4-1654 · Cited by 307
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
Walker, E. C., McGregor, N. E., Poulton, I. J., Solano, M., Pompolo, S., Fernandes, T. J., Constable, M. J., Nicholson, G. C., Zhang, J., Nicola, N. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40568 · Cited by 302
Self-citation
WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk
Zheng, H., Tobias, J. H., Duncan, E. L., Evans, D. M., Eriksson, J., Paternoster, L., Yerges-Armstrong, L. M., Lehtimäki, T. J., Bergström, U., Kähönen, M. A. P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002745 · Cited by 300
Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions
Quinn, J. M. W., Itoh, K., Udagawa, N., Häusler, K., Yasuda, H., Shima, N., Mizuno, A., Higashio, K., Takahashi, N., Suda, T., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1787 · Cited by 278
Self-citation
Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations
Kennedy, O. D., Herman, B. C., Laudier, D. M., Majeska, R. J., Sun, H. B., & Schaffler, M. B. (2012) · Bone · doi:10.1016/j.bone.2012.01.025 · Cited by 275 · cited 2×
“Illustrating this is a study in which microdamage of bone resulted in apoptosis of osteocytes, and increased RANKL production in a closely adjacent group of osteocytes [85].”
Background
The pathobiology of the osteoclast.
Chambers, T. J. (1985) · Journal of Clinical Pathology · doi:10.1136/jcp.38.3.241 · Cited by 275
Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures.
Pfeilschifter, J., Seyedin, S. M., & Mundy, G. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113647 · Cited by 261
Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation
Nicolaidou, V., Wong, M. M., Redpath, A. N., Ersek, A., Baban, D. F., Williams, L. M., Cope, A. P., & Horwood, N. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039871 · Cited by 242
Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time
Smith, M. R., Fred Saad, C., Oudard, S. M., Shore, N. D., Fizazi, K. S., SIEBER, P. R., TOMBAL, B. F., Damião, R., Marx, G. M., Miller, K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.6716 · Cited by 239
Dynamics of bone remodeling
Frost, H. M. (1964) · Medical Entomology and Zoology · Cited by 232
Investigation of cell lineage in bone using a chimaera of chick and quail embryonic tissue
Kahn, A. J., & Simmons, D. J. (1975) · Nature · doi:10.1038/258325a0 · Cited by 231
Dissociation between bone resorption and bone formation in osteopenic transgenic mice
Corral, D. A., Amling, M., Priemel, M., Loyer, E. M., Fuchs, S., Ducy, P. F., Baron, R., & Karsenty, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13835 · Cited by 231
The Cellular Basis of Bone Resorption
Chambers, T. J. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198009000-00039 · Cited by 203
Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Nakamura, M., Udagawa, N., Matsuura, S., Mogi, M., Nakamura, H., Horiuchi, H., Saito, N., Hiraoka, B. Y., Kobayashi, Y., Takaoka, K., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0717 · Cited by 191
Evaluation of Pharmaceuticals With a Novel 50-Hour Animal Model of Bone Loss
Tomimori, Y., Mori, K., Koide, M., Nakamichi, Y., Ninomiya, T., Udagawa, N., & Yasuda, H. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090217 · Cited by 184
Advances in the biology of bone metastasis: How the skeleton affects tumor behavior
Sterling, J. A. R., Edwards, J., Martin, T. J., & Mundy, G. R. (2010) · Bone · doi:10.1016/j.bone.2010.07.015 · Cited by 183
Self-citation
Control of RANKL gene expression
O’Brien, C. A. (2009) · Bone · doi:10.1016/j.bone.2009.08.050 · Cited by 170
Meta-Analysis of Genome-Wide Scans for Total Body BMD in Children and Adults Reveals Allelic Heterogeneity and Age-Specific Effects at the WNT16 Locus
Medina‐Gómez, C., Kemp, J. P., Estrada, K., Eriksson, J., Liu, J., Reppe, S., Evans, D. M., Heppe, D. H. M., Vandenput, L., Herrera, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002718 · Cited by 168
The osteoclast: review of ultrastructure, origin, and structure-function relationship.
Göthlin, G., & Ericsson, J. L. E. (1976) · PubMed · Cited by 155
Osteoclast-Derived Coupling Factors in Bone Remodeling
Henriksen, K., Karsdal, M. A., & Martin, T. J. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9741-7 · Cited by 146
Self-citation
A TNF receptor loop peptide mimic blocks RANK ligand–induced signaling, bone resorption, and bone loss
Aoki, K., Saito, H., Itzstein, C., Ishiguro, M., Shibata, T., Blanqué, R., Mian, A. H., Takahashi, M., Suzuki, Y., Yoshimatsu, M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22513 · Cited by 136
Cord Blood-Derived Macrophage-Lineage Cells Rapidly Stimulate Osteoblastic Maturation in Mesenchymal Stem Cells in a Glycoprotein-130 Dependent Manner
Fernandes, T. J., Hodge, J. M., Singh, P. P., Eeles, D. G., Collier, F., Holten, I. W. R., Ebeling, P. R., Nicholson, G. C., & Quinn, J. M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073266 · Cited by 121
EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone
Takyar, F. M., Tonna, S. J., Ho, P. W. M., Crimeen‐Irwin, B., Baker, E. K., Martin, T. J., & Sims, N. A. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1820 · Cited by 100
Self-citation
Increased presence of capillaries next to remodeling sites in adult human cancellous bone
Kristensen, H. B., Andersen, T. L., Marcussen, N., Rolighed, L., & Delaisse, J.-M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1760 · Cited by 97
EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis
Tonna, S. J., Takyar, F. M., Vrahnas, C., Crimeen‐Irwin, B., Ho, P. W. M., Poulton, I. J., Brennan, H. J., McGregor, N. E., Allan, E. H., Nguyen, H., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-254300 · Cited by 94
Self-citation
Cloning of an osteoblastic cell line involved in the formation of osteoclast‐like cells
Yamashita, T., ASANO, K., Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Martin, T. J., & Suda, T. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450327 · Cited by 87
Self-citation
Physiological Functions of Osteoblast Lineage and T Cell–Derived RANKL in Bone Homeostasis
Fumoto, T., Takeshita, S., Ito, M., & Ikeda, K. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2096 · Cited by 83
Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts
Evely, R. S., Bonomo, A., Schneider, H. G., Moseley, J. M., Gallagher, J. A., & Martin, T. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060114 · Cited by 77
Self-citation
Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity
Furuya, Y., Inagaki, A., Khan, M., Mori, K., Penninger, J. M., Nakamura, M., Udagawa, N., Aoki, K., Ohya, K., Uchida, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426080 · Cited by 77
MATHEMATICAL ELEMENTS OF LAMELLAB BONE REMODELING
Frost, H. M. (1964) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-196409000-00017 · Cited by 68
Osteoprotegerin-Deficient Male Mice as a Model for Severe Alveolar Bone Loss: Comparison With RANKL-Overexpressing Transgenic Male Mice
Koide, M., Kobayashi, Y., Ninomiya, T., Nakamura, M., Yasuda, H., Arai, Y., Okahashi, N., Yoshinari, N., Takahashi, N., & Udagawa, N. (2013) · Endocrinology · doi:10.1210/en.2012-1928 · Cited by 67
Familial Expansile Osteolysis
Wallace, R. G. H., JOHN, R., OSTERBERG, P. H., & Mollan, R. A. B. (1989) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198911000-00043 · Cited by 65
Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo
Walker, E. C., Poulton, I. J., McGregor, N. E., Ho, P. W. M., Allan, E. H., Quach, J., Martin, T. J., & Sims, N. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1506 · Cited by 59
Self-citation
Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts
Kim, J. H., Kim, K., Youn, B. U., Lee, J., Kim, I., Shin, H., Akiyama, H., Choi, Y., & Kim, N. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201308102 · Cited by 53
Heritable disorders of the RANKL/OPG/RANK signaling pathway.
Whyte, M. P., & Mumm, S. R. (2004) · PubMed · Cited by 52
Commitment to the Osteoblast Lineage Is Not Required for RANKL Gene Expression
Galli, C., Fu, Q., Wang, W., Olsen, B. R., Manolagas, S. C., Jilka, R. L., & O’Brien, C. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806628200 · Cited by 51
Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling
Xia, W.-F., Tang, F., Xiong, L., Xiong, S., Jung, J.-U., Lee, D.-H., Li, X.-S., Feng, X., Mei, L., & Xiong, W. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201207154 · Cited by 50
Osteoclast-like cell formation in fetal and newborn long-term baboon marrow cultures is more sensitive to 1,25-dihydroxyvitamin D3 than adult long-term marrow cultures
Takahashi, N., Mundy, G. R., Kuehl, T. J., & Roodman, G. D. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020408 · Cited by 32
Bisphosphonate Therapy Ameliorates Hearing Loss in Mice Lacking Osteoprotegerin
Kanzaki, S., Takada, Y., Ogawa, K., & Matsuo, K. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080812 · Cited by 27
Letter to the editor
Rodan, G. A., & Martin, T. J. (1982) · Calcified Tissue International · doi:10.1007/bf02411258 · Cited by 26
Self-citation
The Physiological Basis of Metabolic Bone Disease
Nordin, B. E. C., Morris, H. A., & Anderson, P. (2014) · CRC Press eBooks · doi:10.1201/b16906 · Cited by 22
Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation
Fujikawa, J., Tanaka, M. H., Itoh, S., Fukushi, T., Kurisu, K., Takeuchi, Y., Morisaki, I., Wakisaka, S., & Abe, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1931-8 · Cited by 15
The Osteoclast
thlin, G. G., & Ericsson, J. L. E. (1976) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197610000-00030 · Cited by 9

Research works printed but not linked: 1

Parfitt AM. Skeletal heterogeneity and the purposes of bone remodelling: Implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego, CA: Academic; 1996. p. 315–39.

Sorted by citations

Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation
Hamblin, M. R. (2017) · Photochemistry and Photobiology · doi:10.1111/php.12864 · Cited by 879
Coupling of bone resorption and formation by RANKL reverse signalling
Ikebuchi, Y., Aoki, S., Honma, M., Hayashi, M., Sugamori, Y., Khan, M., Kariya, Y., Kato, G., Tabata, Y., Penninger, J. M., et al. (2018) · Nature · doi:10.1038/s41586-018-0482-7 · Cited by 557
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Corre, I., Verrecchia, F., Crenn, V., Rédiní, F., & Trichet, V. (2020) · Cells · doi:10.3390/cells9040976 · Cited by 494
The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis
Li, J., Chen, X., Lu, L., & Yu, X. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.02.003 · Cited by 278
Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus
Khosla, S., Samakkarnthai, P., Monroe, D. G., & Farr, J. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00555-5 · Cited by 260

See all 213

Authors: Martin, T. J., & Sims, N. A.
Affiliations: The University of Melbourne (AU)
Corresponding author: Martin, T. John
ORCID: Martin, T. John
Sims, Natalie A.
Venue: Reviews in Endocrine and Metabolic Disorders
Publisher: Springer Science and Business Media LLC
Published: 2015-01-04
Volume: 16
Issue: 2
Pages: 131-139
ISSN: 1389-9155 (ISSN-L)
1573-2606
DOI: 10.1007/s11154-014-9308-6
OpenAlex: W1999943656
Cited by: 213
References: 88
Citations by year: 2026: 15 · 2025: 14 · 2024: 18 · 2023: 19 · 2022: 12 · 2021: 23 · 2020: 29 · 2019: 25 · 2018: 21 · 2017: 26 · 2016: 9 · 2015: 2
FWCI: 1.87
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Reviews in Endocrine and Metabolic Disorders (publishedVersion)
PubMed (publishedVersion)
Funders: National Health and Medical Research Council
National Medical Research Council
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
Keywords: RANKL, osteoprotegerin, RANK, osteoclastogenesis, osteoblast lineage, bone physiology, bone remodeling
MeSH terms: Animals, Bone and Bones, Humans, Mutation, Osteoblasts, Signal Transduction, Paracrine Communication, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

RANKL/OPG; Critical role in bone physiology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks